The FDA approval of Pfizer's vaccine didn't cause the uptick in vaccinations that people had hoped, data showsBusiness Insider • 09/09/21
UK's MHRA Grants Marketing Authorisation for Pfizer's CIBINQO® (abrocitinib) for Adults and Adolescents With Moderate to Severe Atopic DermatitisBusiness Wire • 09/09/21
Moderna Beats Pfizer by This 1 Measure. Here's Why Pfizer Investors Shouldn't Worry.The Motley Fool • 09/08/21
Amazon, Pfizer, Roku, Boeing And More: These Are Cathie Wood's Key Trades From TuesdayBenzinga • 09/08/21
Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Upcoming Healthcare ConferencesBusiness Wire • 09/07/21
Pfizer booster likely to be OK'd by Sept. 20, but Moderna's may lag, Fauci saysMarket Watch • 09/05/21
Pfizer Covid booster shots will likely be ready Sept. 20, but Moderna may be delayed, Fauci saysCNBC • 09/05/21
Did the FDA Move Too Slowly in Fully Approving the Pfizer-BioNTech Vaccine?The Motley Fool • 09/05/21
Why Vaccine Mandates Won't Drive Pfizer, BioNTech, and Moderna Stocks HigherThe Motley Fool • 09/05/21